Onderzoeker
Cools J
- Disciplines (Flanders Institute for Biotechnology):Analyse van next-generation sequence data, Celdood, Kankerbiologie
- Disciplines (KU Leuven):Hematologie, Kankerbiologie
- Zie ook: Jan Cools (KU Leuven)
Affiliaties
- Laboratorium voor Moleculaire Biologie van Leukemie (VIB-KU Leuven) (Afdeling)
Verantwoordelijke
Vanaf1 jan 2008 → Heden - Laboratorium voor Moleculaire Biologie van Leukemie (VIB-KU Leuven) (Afdeling)
Lid
Vanaf1 dec 2017 → Heden - Cools Lab (Onderzoeksgroep)
Verantwoordelijke
Vanaf1 jan 2017 → Heden - Faculteit Geneeskunde (Faculteit)
Lid
Vanaf1 okt 2004 → 30 sep 2005 - Departement Menselijke Erfelijkheid (Departement)
Lid
Vanaf1 okt 1999 → 30 nov 2017
Projecten
1 - 5 of 5
- VIB Grant for Cools Lab_Period:2022-01-01-2026-12-31Vanaf1 jan 2022 → HedenFinanciering: VOI - Projectmatig onderzoek
- HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS’ —‘HARMONY PLUS’Vanaf1 okt 2020 → 30 sep 2023Financiering: Andere Eu-programma's en intiatieven
- Single-cell map of the composition and evolution of T-cell acute lymphoblastic leukemiaVanaf1 apr 2019 → 31 mrt 2021Financiering: HORIZON.1.2 - Marie Skłodowska-Curie-acties (MSCA)
- Health alliance for resourceful medicines offensive against neoplasms in hematologyVanaf1 jan 2017 → 31 dec 2021Financiering: Andere Eu-programma's en intiatieven
- VIB Grant for Cools Lab_Period:2017-01-01-2021-12-31Vanaf1 jan 2017 → 31 dec 2021Financiering: VOI - Projectmatig onderzoek
Publicaties
1 - 10 van 56
- Single cell RNA sequencing reveals endothelial cell killing and resolution pathways in experimental malaria-associated acute respiratory distress syndrome.(2024)
Auteurs: Sofie Demeyer, Jan Cools
Pagina's: e1011929 - Combination therapy of a PSEN1-selective ?-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia.(2023)
Auteurs: Charlien Vandersmissen, Cristina Prieto Fernández, Jan Cools
Pagina's: 2507-2512 - Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer.(2023)
Auteurs: Jan Cools, Diether Lambrechts
Pagina's: 1862-1878 - Targeting STAT5B in T-cell acute lymphoblastic leukemia.(2023)
Auteurs: Alexandra Bacquelaine Veloso, Jan Cools
Pagina's: 215-217 - A review of economic assessments of drought risk reduction approaches in agriculture.(2023)
Auteurs: Jan Cools
Pagina's: 118909 - CRISPR screening in hematology research: from bulk to single-cell level.(2023)
Auteurs: Sarah Meyers, Sofie Demeyer, Jan Cools
Pagina's: 107 - A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-?B signaling.(2023)
Auteurs: Patricia Altea Manzano, Ginevra Doglioni, Alejandro Cuadros, Juan Fernandez Garcia, Qi Wu, Xiaozheng Liu, Oskar Marin Bejar, Sofie Demeyer, Margherita Demicco, Hamza Furkan Alkan, et al.
Pagina's: 344-364 - The Updated European Hematology Association Research Roadmap.(2022)
Auteurs: Jan Cools
Pagina's: e743 - Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosity.(2022)
Auteurs: Koen Debackere, Jan Cools
Pagina's: 603-615 - PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.(2022)
Auteurs: Matteo Rossi, Patricia Altea Manzano, Margherita Demicco, Ginevra Doglioni, Anke Vandekeere, Alejandro Cuadros, Juan Fernandez Garcia, Carla Riera Domingo, Hamza Furkan Alkan, Lindsay Broadfield, et al.
Pagina's: 747-753
Patenten
1 - 3 van 3